We assessed the association between several polymorphisms of angiotensinogen gene (AGT) and essential hypertension using ambulatory blood pressure (BP). Methods: We recruited 802 subjects in a rural Japanese community who were aged Ͼ40 years and who gave written informed consent for monitoring of their ambulatory BP and genetic analysis (the Ohasama Study). As a polymorphism of AGT, Tϩ31C, which is in complete linkage disequilibrium with M235T, was determined using the TaqMan polymerase chain reaction method. Results: The genotype distribution of AGT/Tϩ31C in the Ohasama Study was similar to that in another large
T he angiotensinogen gene (AGT) was first described as a candidate gene associated with essential hypertension. A polymorphism with an amino acid substitution (methionine to threonine) at codon 235 (M235T) in exon 2 of AGT was originally reported to be associated with increased risk for essential hypertension using the affected sib-pair method in 1992. 1 Even though many studies have been performed on the relationship between M235T variants and hypertension, the results have been inconsistent. 2 Meta-analysis suggested that the T235 allele significantly behaves as a marker for essential hypertension in white individuals, but its effect seems to be minor. 3, 4 Recent investigations have identified two polymorphisms, G-6A in the core promoter region and Tϩ31C in exon 1 of AGT, both of which are in absolute linkage disequilibrium with M235T. 5 The G-6A polymorphism has been associated with the transcriptional regulation of AGT, 6 suggesting that G-6A might be more physiologically significant than the M235T. 2 Although the physiologic implication of the AGT/Tϩ31C has not yet been clarified, this genetic variant could be easily determined by TaqMan polymerase chain reaction (PCR), which was established by us. 5, 7 Thus, we examined AGT/Tϩ31C genotype instead of M235T in the general Japanese population.
On the other hand, most studies on the AGT have been performed on the basis of conventional casual blood pres-sure (BP) or a clinical history of hypertension. [1] [2] [3] [4] [5] Conventional casual BP measurements, however, are known to have biases, such as observer bias, regression dilution bias, and the so-called white coat effect. 8 In contrast, 24-h ambulatory BP monitoring allows multiple BP measurements outside the hospital, is free of biases, provides more reproducible information, and has more predictive power than casual BP measurement. 8, 9 Ambulatory BP monitoring also makes it possible to examine circadian BP variation, which has been reported as an independent prognostic indicator. 9 The present study was undertaken to determine the association between the AGT/Tϩ31C and BP value on the basis of ambulatory BP monitoring.
Methods

Study Design
The present study is based on the data obtained from subjects who participated in our BP monitoring and genetic analysis project in a rural community of Ohasama, Iwate, Japan. 10 -13 The characteristics of this area and the details of the study design have been described previously. 9 -11 The study protocol including the genetic analysis was approved by the Institutional Review Board of Tohoku University School of Medicine and by the Department of Health of the Ohasama Town Government.
Study Population for Analysis of Ambulatory BP Values and AGT
We measured the ambulatory BP of 1542 representative subjects in a Japanese community who were aged Ն40 years. 10 Ambulatory BP was measured by a fully automatic device (ABPM 630, Nippon Colin, Komaki, Japan), following the criteria of the Association for the Advancement of Medical Instrumentation. Details of ambulatory BP monitoring have been described previously. 11 In this study, samples were obtained from 802 of these subjects, who gave written informed consent for genetic analysis and have full clinical characteristics.
11
Determination of Genotypes and Biochemical and Hormonal Measurements
Detailed method for the genotype determination of AGT/ Tϩ31C using TaqMan PCR method was described previously. 7 DNA of the participants was amplified by GeneAmp 9700 (Applied Biosystems) under the following conditions: initial denaturation at 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec and 65.5°C for 60 sec. Genotypes of Tϩ31C were then detected by ABI PRISM 7200 Sequence Detection System (Applied Biosystems, Norwalk, CT).
Biochemical and hormonal parameters such as electrocytes, plasma renin activity, creatinine, serum uric acid, and lipid profile were measured with an autoanalyzer. Plasma renin activity was determined by angiotensin I generation (angiotensin I [ng]/plasma [mL]/h incubation).
Data Analysis
Information on smoking status, history of cardiovascular disease, and use of antihypertensive medication was obtained from questionnaires sent to the subjects at the time 
Results
AGT/T؉31C Genotype Distribution and Clinical Characteristics
The frequencies of the TT, CT, and CC genotypes were 0.03, 0.26, and 0.71, respectively, resulted that the calculated frequency of the Cϩ31 allele was 0.83 in the population of the present study. The genotype distribution satisfies Hardy-Weinberg's equilibrium.
Clinical and biochemical features of subjects with ambulatory BP are listed in Table 1 . There was no significant difference in age, proportion of men and women, body mass index, smoking habits, use of antihypertensive medication, prevalence of previous cardiovascular disease, or biochemical and hormonal parameters among the three genotypes.
Relationship Between AGT/T؉31C and Mean BP Values
Mean 24-h ambulatory BP levels did not differ among the three genotypes of AGT/Tϩ31C. Even when the subjects were stratified by sex or age, the obtained results were similar. Nighttime BP, however, tended to be lower in the TT genotype (systolic: P ϭ .086; diastolic: P ϭ .041). Compared with the CT and CC genotypes combined, both systolic and diastolic nighttime BP was significantly lower in subjects with the TT genotype (systolic, P ϭ .035; diastolic, P ϭ .021), as shown in Table 2 .
Relationship Between AGT/T؉31C and Circadian BP Variation
When the percentage of decline in nocturnal BP was compared among the three AGT/Tϩ31C polymorphisms, a significant difference was noted in both systolic and diastolic BP values among these groups (systolic: P ϭ .0090; diastolic: P ϭ .025; see Table 3 ). This association remained significant even after adjustment for possible confounding factors such as age, sex, body mass index, smoking status, use of antihypertensive medication, and prevalence of previous cardiovascular disease (systolic: 17.5% for TT, 13.8% for CT and 13.4% for CC, P ϭ .010; diastolic: 19.9% for TT, 16.4% for CT and 16.1% for CC; P ϭ .026). When the significance of association was compared between CCϩCT and TT, the percentage of decline in nocturnal systolic and diastolic BP was more apparent in subjects with TT than in C allele carriers (systolic P ϭ .0044; diastolic P ϭ .0099; Table 2 ).
Discussion
The present study was designed to determine the association between the AGT/Tϩ31C polymorphism and hypertension in a general Japanese population on the basis of ambulatory BP monitoring. AGT/Tϩ31C polymorphism was clearly determined using the TaqMan PCR method. The results obtained show that the frequency of Cϩ31 allele was 0.83. This result is quite similar to our previous results obtained from another large general population, the Suita Study, 7 as well as a previous meta-analysis of a Japanese population. 14 Recently, Corvol et al 15 emphasized several requirements for the genetic determination of hypertension, including better phenotyping of BP, detailed genetic information, population-based analysis, and stronger statistical power. In the present study, a large number of residents from a rural area (n ϭ 802) participated in the ambulatory BP monitoring, which has greater predictive power than casual BP measurement. Thus, the present finding that AGT/Tϩ31C has little effect on the BP level of a general Japanese population strongly suggests the absence of a direct effect of this genetic polymorphism on BP level. Nighttime BP, however, was significantly lower in subjects with the TT genotype. As the nocturnal BP decline was greater in these subjects, a lower nighttime BP level is thought to involve a circadian BP variation in TT genotypes. However, we should keep in mind the possibility that the present finding might be an effect of chance due to a smaller number of subjects with TT genotype. We conclude that AGT/Tϩ31C may be associated with circadian BP variation. Abbreviation as in Table 2 .
Statistical significance determined by analysis of variance or 2 among three groups. Percentage data expressed as mean Ϯ SD. Nondipper defined as nocturnal decline Ͻ10%. Dipper defined as nocturnal decline Ն10%. * P Ͻ .05.
